Arrow Greentech Ltd

₹ 531 6.30%

29 May - close price

arrowgreentech.com BSE: 516064 NSE: ARROWGREEN

About

Incorporated in 1982, Arrow Greentech
Ltd is in the business of bio-degradable (green) products, high-tech products and having Patents income for such products /technology^[1]

Key Points

Business Overview:^[1]^[2]
AGL is India’s largest manufacturer of water-soluble films, specializing in the development, production, and marketing of a diverse range of PVA/PVOH-based films. Its portfolio includes innovative applications such as mouth dissolving strips for pharmaceutical and nutraceutical use. In addition to green packaging solutions, AGL also offers advanced security products and intellectual property services, positioning itself as a multi-vertical technology-driven company.

Website BSE NSE

Market Cap ₹ 800 Cr.
Current Price ₹ 531
High / Low ₹ 818 / 342
Stock P/E 16.9
Book Value ₹ 155
Dividend Yield 0.75 %
ROCE 30.4 %
ROE 22.4 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.
Company has delivered good profit growth of 51.1% CAGR over last 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 28.9%

Cons

Promoter holding has decreased over last 3 years: -3.77%
Working capital days have increased from 142 days to 239 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Industrials Capital Goods Industrial Products Packaging

Part of BSE Industrials

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	48.14	43.86	29.12	24.91	50.62	66.11	64.84	55.11	57.29	41.60	61.07	56.06	41.78
	29.54	29.49	20.12	17.61	35.00	38.05	38.54	37.19	41.25	27.35	40.32	36.85	31.41
Operating Profit	18.60	14.37	9.00	7.30	15.62	28.06	26.30	17.92	16.04	14.25	20.75	19.21	10.37
OPM %	38.64%	32.76%	30.91%	29.31%	30.86%	42.44%	40.56%	32.52%	28.00%	34.25%	33.98%	34.27%	24.82%
	1.25	0.71	0.57	0.64	0.68	0.80	1.14	1.56	1.76	1.88	2.12	2.15	2.38
Interest	0.38	0.09	0.09	0.10	0.16	0.03	0.05	0.08	0.05	0.06	0.12	0.12	0.08
Depreciation	1.80	1.71	1.97	2.11	2.05	1.74	1.72	1.90	2.03	1.81	1.98	1.94	2.04
Profit before tax	17.67	13.28	7.51	5.73	14.09	27.09	25.67	17.50	15.72	14.26	20.77	19.30	10.63
Tax %	27.50%	29.82%	32.62%	14.83%	28.81%	25.58%	27.50%	26.69%	27.54%	23.42%	24.22%	31.14%	30.01%
	12.81	9.32	5.06	4.88	10.03	20.16	18.61	12.83	11.39	10.92	15.74	13.29	7.44
EPS in Rs	8.46	6.19	3.38	3.25	6.71	13.36	12.37	8.52	7.58	7.22	10.43	8.82	4.90
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	49	51	53	35	34	22	52	34	109	149	243	201
	19	14	16	29	49	29	44	41	85	102	155	136
Operating Profit	29	37	36	5	-14	-7	9	-7	24	47	89	65
OPM %	60%	73%	69%	16%	-42%	-34%	17%	-21%	22%	31%	36%	32%
	1	5	5	2	1	1	2	2	2	3	5	9
Interest	0	0	0	0	0	1	1	1	1	1	0	0
Depreciation	1	1	2	4	4	4	5	5	7	8	7	8
Profit before tax	30	41	39	3	-17	-10	6	-11	18	41	86	65
Tax %	22%	24%	12%	95%	-1%	-2%	-22%	-16%	32%	28%	27%	27%
	22	31	35	0	-17	-10	7	-9	12	29	63	47
EPS in Rs	15.84	21.67	24.19	0.19	-11.83	-7.07	4.55	-6.62	8.14	19.56	41.84	31.38
Dividend Payout %	13%	17%	19%	870%	-4%	0%	0%	0%	12%	10%	10%	0%

Compounded Sales Growth
10 Years:	15%
5 Years:	31%
3 Years:	23%
TTM:	-18%

Compounded Profit Growth
10 Years:	5%
5 Years:	51%
3 Years:	57%
TTM:	-24%

Stock Price CAGR
10 Years:	1%
5 Years:	38%
3 Years:	13%
1 Year:	-16%

Return on Equity
10 Years:	15%
5 Years:	22%
3 Years:	29%
Last Year:	22%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	12	12	12	12	12	14	14	14	15	15	15	15
Reserves	35	58	86	86	66	62	70	61	83	112	173	219
	0	0	0	0	0	5	5	5	3	1	1	2
	13	16	8	8	9	10	9	9	20	17	19	19
Total Liabilities	60	86	106	106	87	92	99	89	121	145	208	256
	11	16	26	26	23	28	26	28	37	37	38	38
CWIP	1	1	1	1	2	10	12	13	1	3	2	0
Investments	15	15	18	29	17	14	9	1	0	0	46	77
	33	53	60	49	45	40	53	46	83	104	123	141
Total Assets	60	86	106	106	87	92	99	89	121	145	208	256

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	26	27	17	5	-16	3	1	2	3	18	68	43
	-11	-6	-12	-13	8	-24	2	-2	-14	-14	-55	-26
	-4	-7	-2	-6	-3	12	-2	-2	8	-4	-4	-7
Net Cash Flow	11	14	2	-14	-11	-8	2	-1	-3	1	9	10
Free Cash Flow	22	21	4	2	-23	-15	-4	-6	-1	8	61	39
CFO/OP	107%	94%	78%	159%	109%	-53%	17%	-33%	25%	71%	103%	94%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	4	40	66	84	81	56	49	40	88	79	44	62
Inventory Days	78		229	204	84	99	51	127	101	138	66	101
Days Payable	153		267	111	49	80	27	60	68	31	29	22
Cash Conversion Cycle	-71	40	28	178	116	75	73	106	121	187	81	141
Working Capital Days	-68	-35	57	119	116	59	95	112	104	117	70	239
ROCE %	76%	69%	46%	3%	-19%	-12%	7%	-12%	21%	35%	53%	30%

Insights

In beta

Mar 2015

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Employee Benefit Expenses
INR Lakhs ・Standalone data

xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	x,xxx.xx
xx	xx		xx	xx	xx	xx	xx	xx	xx	xx
	xx		xx	xx	xx	xx	xxx	x,xxx	x,xxx	xxx
								xx	xx	xx
								xx	xx	xx
								xx	xx	xx

Please log in to see hidden values.

Total Granted Patents (Cumulative)
Number

Number of Employees
Number

FSSAI Approved Products (Avery Pharma)
Number

Prescription (Rx) Approved Products
Number

Registered Trademarks (India)
Number

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

3 Recently

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	68.60%	68.60%	68.60%	68.60%	68.60%	66.75%	64.81%	64.81%	64.81%	64.81%	64.81%	64.83%
	0.00%	0.02%	0.00%	1.28%	0.21%	0.09%	0.56%	0.27%	0.25%	0.12%	0.14%	0.06%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.04%	0.11%	0.69%	0.79%	0.82%
	31.41%	31.38%	31.42%	30.13%	31.19%	33.16%	34.63%	34.88%	34.84%	34.38%	34.25%	34.28%
No. of Shareholders	8,201	8,137	12,630	13,430	14,838	22,320	22,038	22,605	21,685	21,947	21,521	21,442

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	69.68%	65.42%	65.42%	70.35%	70.28%	70.35%	68.60%	68.60%	64.81%	64.83%
	0.80%	1.30%	0.83%	0.10%	0.21%	0.00%	0.13%	1.28%	0.27%	0.06%
	0.35%	8.16%	1.95%	0.14%	0.00%	0.00%	0.00%	0.00%	0.04%	0.82%
	29.18%	25.12%	31.80%	29.41%	29.52%	29.65%	31.28%	30.13%	34.88%	34.28%
No. of Shareholders	5,981	8,578	9,402	8,595	7,638	8,934	7,760	13,430	22,605	21,442

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

Right Issue

Concalls

Feb 2026

Transcript

AI Summary
PPT
Nov 2025

Transcript

AI Summary
PPT
Aug 2025

Transcript

AI Summary
PPT
May 2025

Transcript

AI Summary
PPT
Feb 2025

Transcript

AI Summary
PPT
Oct 2024

Transcript

AI Summary
PPT
May 2024

Transcript

AI Summary
PPT
May 2024

Transcript

AI Summary
PPT
May 2024

Transcript

AI Summary
PPT
Feb 2024

Transcript

AI Summary
PPT
Nov 2023

Transcript

AI Summary
PPT
Jun 2023

Transcript

AI Summary
PPT
Nov 2019

Transcript

AI Summary
PPT
Feb 2019

Transcript

AI Summary
PPT
Aug 2016

Transcript

AI Summary
PPT
May 2016

Transcript

AI Summary
PPT
Nov 2015

Transcript

AI Summary
PPT
Aug 2015

Transcript

AI Summary
PPT